Login
$OCG
$1.60 +$0.03 (1.91%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q4 FY2020
As of Dec 31, 2020
Current assets
Cash and cash equivalents
Restricted cash
Short-term investments
Restricted investment
Accounts receivable, net
Inventory
Other receivables and prepaid expenses
Other receivable - related party
Total current assets
Property and equipment, net
Other assets
Prepaid expenses - non current
Right-of-use assets
Cost method investments
Intangible assets, net
Deferred tax assets, net
Total other assets
Total assets
Current liabilities
Other payables and accrued liabilities
Accounts payable
Accounts payable - related parties
Deferred revenue
Other payables and accrued liabilities
Taxes payable
Lease liability - current
Total current liabilities
Total liabilities
Shareholders’ Equity
Preferred shares, $0.00005 par value, 100,000,000 shares authorized, 12,000,000 and 0 shares issued and outstanding as of December 31, 2025 and 2024, respectively
Ordinary shares, $0.165 par value, 3,000,000 and 272,728 shares authorized, 151,873 and 31,048 shares issued, 148,960 and 28,135 shares outstanding as of December 31, 2025 and 2024, respectively*
Treasury shares, at cost, 2,913 shares issued as of December 31, 2025 and 2024, respectively*
Additional paid-in capital
Statutory reserves
Retained earnings
Accumulated other comprehensive loss
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support